Guy Debrock

A phase II trial with rosiglitazone in liposarcoma patients

Guy Debrock, V Vanhentenrijk, Raf Sciot et al. · British Journal of Cancer · 2003 · 158 citations · Full text

Medicine, Oncology, Pharmacology +15

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters

Barbara Brouwers, Sigrid Hatse, Lissandra Dal Lago et al. · Oncotarget · 2016 · 52 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer

Hans Wildiers, Patrick Neven, Marie‐Rose Christiaens et al. · Annals of Oncology · 2010 · 28 citations · Full text

Medicine, Oncology, Pharmacology +16

The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥ 70 with early stage invasive breast cancer

Chantal Quinten, Cindy Kenis, Marije E. Hamaker et al. · Journal of Geriatric Oncology · 2017 · 21 citations

Medicine, Geriatric Medicine, Oncology +16

Multicenter phase II study of neoadjuvant capecitabine (X), docetaxel (T) +/- trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): Preliminary safety and efficacy data

Willem Lybaert, Hans Wildiers, Patrick Neven et al. · Breast Cancer Research and Treatment · 2006 · 12 citations

Medicine, Oncology, Pharmacology +17